ES2094622T3 - Derivados triterpenos y antagonistas del receptor de endotelina que los contiene. - Google Patents
Derivados triterpenos y antagonistas del receptor de endotelina que los contiene.Info
- Publication number
- ES2094622T3 ES2094622T3 ES94304165T ES94304165T ES2094622T3 ES 2094622 T3 ES2094622 T3 ES 2094622T3 ES 94304165 T ES94304165 T ES 94304165T ES 94304165 T ES94304165 T ES 94304165T ES 2094622 T3 ES2094622 T3 ES 2094622T3
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- triterpen
- antagonists
- hydrogen
- endothelin receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000010180 Endothelin receptor Human genes 0.000 title 1
- 108050001739 Endothelin receptor Proteins 0.000 title 1
- 229930194930 Triterpen Natural products 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004185 ester group Chemical group 0.000 abstract 2
- 230000002503 metabolic effect Effects 0.000 abstract 2
- 102000002045 Endothelin Human genes 0.000 abstract 1
- 108050009340 Endothelin Proteins 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 150000003648 triterpenes Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14041693 | 1993-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2094622T3 true ES2094622T3 (es) | 1997-01-16 |
Family
ID=15268217
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94304165T Expired - Lifetime ES2094622T3 (es) | 1993-06-11 | 1994-06-09 | Derivados triterpenos y antagonistas del receptor de endotelina que los contiene. |
| ES95112524T Expired - Lifetime ES2116663T3 (es) | 1993-06-11 | 1994-06-09 | Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95112524T Expired - Lifetime ES2116663T3 (es) | 1993-06-11 | 1994-06-09 | Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5463107A (enExample) |
| EP (2) | EP0628569B1 (enExample) |
| JP (1) | JP2724114B2 (enExample) |
| KR (1) | KR100201015B1 (enExample) |
| CN (2) | CN1041938C (enExample) |
| AT (2) | ATE142640T1 (enExample) |
| DE (2) | DE69400506T2 (enExample) |
| DK (1) | DK0628569T3 (enExample) |
| ES (2) | ES2094622T3 (enExample) |
| GR (1) | GR3021952T3 (enExample) |
| TW (1) | TW272974B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0628569B1 (en) | 1993-06-11 | 1996-09-11 | Shionogi & Co., Ltd. | Triterpene derivatives and endothelin-receptor antagonists containing the same |
| BR9608413A (pt) * | 1995-06-02 | 1998-12-29 | Shionogi & Co | Inibidor de edema cerebral |
| WO1997027314A1 (fr) * | 1996-01-23 | 1997-07-31 | Shionogi & Co., Ltd. | Processus de production d'analogues d'acide oleanolique par la culture de racine pileuse |
| JP2007217438A (ja) * | 2001-07-17 | 2007-08-30 | Shionogi & Co Ltd | 注射用医薬製剤 |
| TWI232102B (en) * | 2001-07-17 | 2005-05-11 | Shionogi & Co | A pharmaceutical formulation for injection |
| US7223882B2 (en) | 2002-03-22 | 2007-05-29 | Shionogi & Co., Ltd. | Process for producing triterpene derivative |
| EP1629853A1 (en) * | 2003-06-04 | 2006-03-01 | SHIONOGI & CO., LTD. | Method for preparing powder exhibiting low susceptibility to electrification |
| TWI335335B (en) * | 2004-03-24 | 2011-01-01 | Shionogi & Co | A novel crystal of a triterpene derivative |
| EP1757573A4 (en) | 2004-05-14 | 2008-05-07 | Shionogi & Co | Oxidation reaction of alcohol with hydrogen peroxide and tungsten catalyst |
| JPWO2006077801A1 (ja) * | 2005-01-18 | 2008-06-19 | 塩野義製薬株式会社 | ミリセロン誘導体の製造方法 |
| TW200731966A (en) * | 2005-12-21 | 2007-09-01 | Shionogi & Co | A pharmaceutical composition or a method for treating ischemic stroke |
| US7323476B2 (en) * | 2006-03-03 | 2008-01-29 | Savipu Pharmaceuticals | Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases |
| US20070207989A1 (en) * | 2006-03-03 | 2007-09-06 | Savipu Pharmaceuticals | Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases |
| WO2007103727A2 (en) * | 2006-03-03 | 2007-09-13 | Savipu Pharmaceuticals | Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb |
| US20070243273A1 (en) * | 2006-04-12 | 2007-10-18 | Savipu Pharmaceuticals | Reduction of the Deleterious Effects of Tobacco Smoking |
| US20080017207A1 (en) * | 2006-07-18 | 2008-01-24 | Savipu Pharmaceuticals | Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2 |
| US20080187608A1 (en) * | 2007-02-05 | 2008-08-07 | Savipu Pharmaceuticals | Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases |
| US20090022821A1 (en) * | 2007-07-17 | 2009-01-22 | Inderjit Kumar Dev | Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5248807A (en) | 1991-01-29 | 1993-09-28 | Shionogi & Co., Ltd. | Triterpene derivatives |
| EP0628569B1 (en) | 1993-06-11 | 1996-09-11 | Shionogi & Co., Ltd. | Triterpene derivatives and endothelin-receptor antagonists containing the same |
-
1994
- 1994-06-09 EP EP94304165A patent/EP0628569B1/en not_active Expired - Lifetime
- 1994-06-09 DE DE69400506T patent/DE69400506T2/de not_active Expired - Lifetime
- 1994-06-09 TW TW083105247A patent/TW272974B/zh not_active IP Right Cessation
- 1994-06-09 DE DE69410081T patent/DE69410081T2/de not_active Expired - Lifetime
- 1994-06-09 DK DK94304165.7T patent/DK0628569T3/da active
- 1994-06-09 AT AT94304165T patent/ATE142640T1/de not_active IP Right Cessation
- 1994-06-09 EP EP95112524A patent/EP0682009B1/en not_active Expired - Lifetime
- 1994-06-09 ES ES94304165T patent/ES2094622T3/es not_active Expired - Lifetime
- 1994-06-09 AT AT95112524T patent/ATE165811T1/de not_active IP Right Cessation
- 1994-06-09 ES ES95112524T patent/ES2116663T3/es not_active Expired - Lifetime
- 1994-06-09 JP JP6127420A patent/JP2724114B2/ja not_active Expired - Fee Related
- 1994-06-10 US US08/258,392 patent/US5463107A/en not_active Expired - Lifetime
- 1994-06-10 KR KR1019940013068A patent/KR100201015B1/ko not_active Expired - Fee Related
- 1994-06-10 CN CN94102805A patent/CN1041938C/zh not_active Expired - Fee Related
-
1995
- 1995-07-26 US US08/507,211 patent/US5587505A/en not_active Expired - Lifetime
-
1996
- 1996-12-10 GR GR960403369T patent/GR3021952T3/el unknown
-
1998
- 1998-05-20 CN CN98109227A patent/CN1070183C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0682009A3 (en) | 1997-02-05 |
| DE69400506D1 (de) | 1996-10-17 |
| CN1070183C (zh) | 2001-08-29 |
| TW272974B (enExample) | 1996-03-21 |
| DE69410081D1 (de) | 1998-06-10 |
| CN1215725A (zh) | 1999-05-05 |
| ATE142640T1 (de) | 1996-09-15 |
| DE69400506T2 (de) | 1997-02-13 |
| JPH0753484A (ja) | 1995-02-28 |
| US5587505A (en) | 1996-12-24 |
| ATE165811T1 (de) | 1998-05-15 |
| DK0628569T3 (da) | 1996-09-30 |
| KR100201015B1 (ko) | 1999-06-15 |
| KR950000663A (ko) | 1995-01-03 |
| CN1106368A (zh) | 1995-08-09 |
| EP0628569B1 (en) | 1996-09-11 |
| JP2724114B2 (ja) | 1998-03-09 |
| US5463107A (en) | 1995-10-31 |
| DE69410081T2 (de) | 1998-10-08 |
| EP0682009A2 (en) | 1995-11-15 |
| ES2116663T3 (es) | 1998-07-16 |
| CN1041938C (zh) | 1999-02-03 |
| GR3021952T3 (en) | 1997-03-31 |
| EP0628569A1 (en) | 1994-12-14 |
| EP0682009B1 (en) | 1998-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0628569T3 (da) | Triterpenderivater og endothelinreceptorantagonister indeholdende samme | |
| ES2117249T3 (es) | Derivados de 2,6-diaminopurina. | |
| ES2086270T5 (es) | Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos. | |
| ES2117034T3 (es) | Composicion para la limpieza de vidrio. | |
| MX9102407A (es) | 4 arilpiperazinas y 4-arilpiperidinas novedosas. | |
| DK1920764T3 (da) | Fluprostenolisopropylester til anvendelse i behandling af glaukom og okulær hypertension | |
| ES2113127T3 (es) | Derivado de androstenona. | |
| ES2172580T3 (es) | 1,3-oxatiolanos sustituidos con propiedades antiviricas. | |
| ATE164588T1 (de) | Triterpenderivat | |
| ES2082875T3 (es) | 3,5-di-terc-butil-4-hidroxifenilmetileno-derivados de tiazolidinonas, oxazolidinonas e imidazolidinonas 2-sustituidas utiles como agentes antiinflamatorios. | |
| ES2040106T3 (es) | Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma. | |
| ES2154262T3 (es) | Uso de compuestos macrolidos para enfermedades oculares. | |
| ES2040879T3 (es) | Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina. | |
| DK599789D0 (da) | 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler | |
| PE13391A1 (es) | Procedimiento de preparacion de derivados de piperazina | |
| ES2123873T3 (es) | Pirrolocarbazol. | |
| FI906296A0 (fi) | Nya metylenbisfosfonsyrederivat. | |
| FI851261A0 (fi) | Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| ES2083708T3 (es) | Nuevas piperazinilalcoil-3 dihidro-2,3,4h-benzoxazina-1,3 onas-4 sustituidas, su preparacion y su aplicacion en terapeutica. | |
| AR007052A1 (es) | Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende | |
| IL90559A0 (en) | Analgetic derivatives of phenothiazine | |
| EP0150015A3 (en) | Norbornane and norbornene carboxylic acid amides, process for their preparation and their use as medicines | |
| ES2166838T3 (es) | 6-(triazolil(3-(trifluorometil)fenil)metil)-2-quinolinonas y -quinolinationas. | |
| ATE144252T1 (de) | Methanoanthracene als dopaminantagonisten | |
| ES2089399T3 (es) | Composicion para el tratamiento del cabello que contiene un compuesto de perfluoropolieter y un agente nacarante. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 628569 Country of ref document: ES |